Tudor Investment Corp’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5K | Sell |
29,729
-203
| -0.7% | -$235 | ﹤0.01% | 1492 |
|
|
2025
Q1 | $40.4K | Buy |
+29,932
| New | +$40.4K | ﹤0.01% | 1461 |
|
|
2024
Q4 | – | Sell |
-22,628
| Closed | -$254K | – | 1978 |
|
|
2024
Q3 | $254K | Sell |
22,628
-9,618
| -30% | -$108K | ﹤0.01% | 1368 |
|
|
2024
Q2 | $347K | Buy |
32,246
+5,349
| +20% | +$57.5K | ﹤0.01% | 1271 |
|
|
2024
Q1 | $401K | Buy |
+26,897
| New | +$401K | ﹤0.01% | 1160 |
|
|
2023
Q3 | – | Sell |
-27,725
| Closed | -$502K | – | 1842 |
|
|
2023
Q2 | $502K | Sell |
27,725
-18,482
| -40% | -$335K | 0.01% | 1133 |
|
|
2023
Q1 | $1.23M | Buy |
46,207
+22,078
| +91% | +$587K | 0.02% | 830 |
|
|
2022
Q4 | $466K | Buy |
24,129
+153
| +0.6% | +$2.96K | 0.01% | 1141 |
|
|
2022
Q3 | $501K | Buy |
+23,976
| New | +$501K | 0.01% | 1102 |
|